ENTRY       D10066                      Drug
NAME        Dolutegravir (USAN);
            Tivicay (TN)
FORMULA     C20H19F2N3O5
EXACT_MASS  419.1293
MOL_WEIGHT  419.3788
CLASS       Antiviral
             DG03107  Anti-HIV agent
              DG03135  HIV integrase inhibitor
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
             DG02924  UGT substrate
              DG03183  UGT1A1 substrate
            Transporter inhibitor
             DG02863  SLC22A2 inhibitor
             DG02864  SLC47A1 inhibitor
REMARK      ATC code: J05AJ03
            Chemical structure group: DG00667
            Product (DG00667): D10113<JP/US>
            Product (mixture): D10600<JP/US> D11522<JP/US>
EFFICACY    Antiviral, HIV integrase inhibitor
COMMENT     Treatment of HIV infection
TARGET      HIV-1 integrase [KO:K24803]
  PATHWAY   ko03230(K24803)  Viral genome structure
            ko03240(K24803)  Viral replication
            ko03250(K24803)  Viral life cycle - HIV-1
METABOLISM  Enzyme: UGT1A1 [HSA:54658]; CYP3A4 [HSA:1576]
INTERACTION Transporter inhibition: SLC22A2 [HSA:6582], SLC47A1 [HSA:55244]
STR_MAP     map07053  Anti-HIV agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J05 ANTIVIRALS FOR SYSTEMIC USE
               J05A DIRECT ACTING ANTIVIRALS
                J05AJ Integrase inhibitors
                 J05AJ03 Dolutegravir
                  D10066  Dolutegravir (USAN)
            Drug groups [BR:br08330]
             Antiviral
              DG03107  Anti-HIV agent
               DG03135  HIV integrase inhibitor
                DG00667  Dolutegravir
                 D10066  Dolutegravir
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00667  Dolutegravir
                 D10066  Dolutegravir
              DG02924  UGT substrate
               DG03183  UGT1A1 substrate
                DG00667  Dolutegravir
                 D10066  Dolutegravir
             Transporter inhibitor
              DG02863  SLC22A2 inhibitor
               DG00667  Dolutegravir
                D10066  Dolutegravir
              DG02864  SLC47A1 inhibitor
               DG00667  Dolutegravir
                D10066  Dolutegravir
            Antimicrobials [BR:br08307]
             Antivirals
              Genome replication inhibitor
               HIV integrase inhibitor
                D10066  Dolutegravir (USAN)
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D10066
             Drug transporters
              D10066
            Drug groups [BR:br08330]
             Antiviral
              DG03107  Anti-HIV agent
               DG03135  HIV integrase inhibitor
                DG00667  Dolutegravir
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00667  Dolutegravir
              DG02924  UGT substrate
               DG03183  UGT1A1 substrate
                DG00667  Dolutegravir
             Transporter inhibitor
              DG02863  SLC22A2 inhibitor
               DG00667  Dolutegravir
              DG02864  SLC47A1 inhibitor
               DG00667  Dolutegravir
            Antimicrobials abbreviations [BR:br08327]
             Antivirals
              Genome replication inhibitor
               HIV integrase inhibitor
                DG00667  Dolutegravir
DBLINKS     CAS: 1051375-16-6
            PubChem: 135626786
            ChEBI: 76010
            PDB-CCD: DLU
            LigandBox: D10066
ATOM        30
            1   C8y C    17.0100  -20.8600
            2   N4y N    17.0100  -19.4600
            3   C8x C    18.2000  -18.7600
            4   C8y C    19.4600  -19.4600
            5   C8y C    19.4600  -20.8600
            6   C8y C    18.2000  -21.5600
            7   C5x C    15.8200  -21.5600
            8   N1y N    14.5600  -20.8600
            9   C1y C    14.5600  -19.4600
            10  C1x C    15.8200  -18.7600
            11  C1y C    13.3700  -21.5600
            12  C1x C    12.1800  -20.8600
            13  C1x C    12.1800  -19.4600
            14  O2x O    13.3700  -18.7600
            15  O5x O    15.8200  -22.9600
            16  O1a O    18.2000  -22.9600
            17  O5x O    20.6500  -21.5600
            18  C5a C    20.6500  -18.7600
            19  N1b N    21.8400  -19.4600
            20  O5a O    20.6500  -17.3600
            21  C1b C    23.0300  -18.7600
            22  C8y C    24.2200  -19.4600
            23  C8x C    25.4100  -18.7600
            24  C8x C    26.6700  -19.4600
            25  C8y C    26.6700  -20.8600
            26  C8x C    25.4800  -21.5600
            27  C8y C    24.2200  -20.8600
            28  X   F    23.0300  -21.5600
            29  X   F    27.8600  -21.5600
            30  C1a C    14.5600  -22.2600
BOND        33
            1     1   2 1
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 1
            6     1   6 2
            7     1   7 1
            8     7   8 1
            9     8   9 1
            10    9  10 1
            11    2  10 1
            12    8  11 1
            13   11  12 1
            14   12  13 1
            15   13  14 1
            16    9  14 1
            17    7  15 2
            18    6  16 1
            19    5  17 2
            20    4  18 1
            21   18  19 1
            22   18  20 2
            23   19  21 1
            24   21  22 1
            25   22  23 2
            26   23  24 1
            27   24  25 2
            28   25  26 1
            29   26  27 2
            30   22  27 1
            31   27  28 1
            32   25  29 1
            33   11  30 1 #Down
///
